Use access key #2 to skip to page content.
$23.66 -1.83 (-7.18%)
10/6/2008 4:00 PM

BioMarin Pharmaceutical, Inc. (BMRN)

CAPS Rating:
****

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

View All Commentary (BMRN)

Recs

6

Avatar TMFBreakerCharly (90.45) Submitted: 4/27/06 1:35 AM : Outperform Start Price: $12.13 BMRN Score: 114.36

This company has very good products for rare genetic diseases and absolutely no competition. The company is probably worth $25 if its drug Phenoptin works. I expect it will get bought out at some point in the next few years as its pipeline is pretty thin.

Report this Post Replies: 0 | Reply

Featured Broker Partners